References
- Baudin E, Cao CD, Cailleux AF, et al (2003). Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab, 88, 1107-11. https://doi.org/10.1210/jc.2002-021365
-
Berger F, Friedrich U, Knesewitsch P, Hahn K (2011). Diagnostic
$^{131}I$ whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and longterm follow-up. Eur J Nucl Med Mol Imaging, 38, 451-8. https://doi.org/10.1007/s00259-010-1657-0 - Castagna MG, Maino F, Cipri C, et al (2011). Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol, 165, 441-6. https://doi.org/10.1530/EJE-11-0466
- Cooper DS, Doherty GM, Haugen BR, et al (2009). Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 91, 1167-214.
- Durante C, Costante G, Filetti S (2013). Differentiated thyroid carcinoma: defining new paradigms for postoperative management. Endocr Relat Cancer, 20, 141-54. https://doi.org/10.1530/ERC-13-0066
- Francis Z, Schlumberger M (2008). Serum thyroglobulin determination in thyroid cancer patients. Best Pract Res Clin Endocrinol Metab, 22, 1039-46. https://doi.org/10.1016/j.beem.2008.09.015
- Frasoldati A, Pesenti M, Gallo M, et al (2003). Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 97, 90-6. https://doi.org/10.1002/cncr.11031
- Ibrahimpasic T, Nixon IJ, Palmer FL, et al (2012). Undetectable thyroglobulin after total thyroidectomy in patients with lowand intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy? Surgery, 152, 1096-105. https://doi.org/10.1016/j.surg.2012.08.034
- Ito Y, Kudo T, Kihara M, et al (2012). Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors. Endocr J, 59, 119-25. https://doi.org/10.1507/endocrj.EJ11-0288
-
Kim TY, Kim WB, Kim ES, et al (2005). Serum thyroglobulin levels at the time of
$^{131}I$ remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab, 90, 1440-5. https://doi.org/10.1210/jc.2004-1771 -
Koh JM, Kim ES, Ryu JS, et al (2003). Effects of therapeutic doses of
$^{131}I$ in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131-I whole-body scan: comparative study. Clin Endocrinol, 58, 421-7. https://doi.org/10.1046/j.1365-2265.2003.01733.x - Kucukalic-Selimovic E, Alagic J, Valjevac A, et al (2012). The value of serum thyreoglobulin levels and whole body (I-131) scintigraphy in the follow-up of the thyroid cancer patients after thyroidectomy. Coll Antropol, 2, 67-71.
- Lee JI, Chung YJ, Cho BY, et al (2013). Postoperative-stimulated serum thyroglobulin measured at the time of 131-I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. Surgery, 153, 828-35. https://doi.org/10.1016/j.surg.2012.12.008
- Leenhardt L, Erdogan MF, Hegedus L, et al (2013). Europan Thyroid Association Guidelines for cervical ultrasound scan and ultrasound-guide techniques in the postoperative mangement of patients with thyroid cancer. Eur Thyroid J, 2, 147-59. https://doi.org/10.1159/000354537
- Nascimento C, Borget I, Al Ghuzlan A, et al (2011). Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. Endocr Relat Cancer, 18, 29-40.
- Pacini F, Capezzone M, Elisei R, et al (2002). Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab, 87, 1499-501. https://doi.org/10.1210/jcem.87.4.8274
- Tuttle RM, Tala H, Shah J, et al (2010). Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid, 20, 1341-9. https://doi.org/10.1089/thy.2010.0178
Cited by
- Diagnostic value of Thyroglobulin Measurement with Fine-needle Aspiration Biopsy for Lymph Node Metastases in Patients with a History of Differentiated Thyroid Cancer vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10905
- Factors Affecting Disease-Free Status of Differentiated Thyroid Carcinoma Patients vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.737
- Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma pp.1600-0455, 2017, https://doi.org/10.1177/0284185117721261